Spots Global Cancer Trial Database for Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
Official Title: Clinical Research Platform on Treatment, Quality of Life and Outcome of Patients With Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
Study ID: NCT06043011
Interventions
Study Description
Brief Summary: The purpose of the project is to set up a national, prospective, longitudinal, multicenter registry platform to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with hematological malignancies in Germany.
Detailed Description: RUBIN is a national, observational, prospective, longitudinal, multicenter registry platform with the purpose to record information on the antineoplastic treatment of hematological malignancies in Germany. It will identify common therapeutic sequences and changes in the treatment of the disease, and will analyse the impact of novel treatments on the outcome of patients in routine care. Unmet needs and areas with the potential for improvement in routine care are to be identified. At inclusion, data in patient characteristics, comorbidities, clinical characteristics and previous treatments, if applicable, are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and clinical outcome are documented. Health-realted quality of life in patients with hematological malignancies will be evaluated for up to one year.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Praxis fßr Interdisziplinäre Hämatologie und Onkologie, Freiburg, , Germany
Contact Details
Name: Rainer Claus, Prof. Dr.
Affiliation: Universitätsklinikum Augsburg, Germany
Role: STUDY_CHAIR
Name: Tobias Dechow
Affiliation: Studienzentrum Onkologie Ravensburg, Germany
Role: STUDY_CHAIR
Name: Paul Graf La RosĂŠe, Prof. Dr.
Affiliation: Schwarzwald-Baar Klinikum, Germany
Role: STUDY_CHAIR
Name: Jens Kisro, Dr.
Affiliation: LĂźbecker Onkologische Schwerpunktpraxis, Germany
Role: STUDY_CHAIR
Name: Patrick Marschner, Dr.
Affiliation: Praxis fßr Interdisziplinäre Hämatologie und Onkologie, Freiburg, Germany
Role: STUDY_CHAIR
Name: Ingo Tamm, PD Dr.
Affiliation: Onkologische Schwerpunktpraxis KurfĂźrstendamm, Berlin, Germany
Role: STUDY_CHAIR
Name: Robert Zeiser, Prof. Dr.
Affiliation: Universitätsklinikum Freiburg, Germany
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
